検索結果

千寿製薬株式会社

NEWS & RELEASE December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Pot

Mytear EYETECT ALPITATTO | OTC Products, etc. | Products | SENJU Pharmaceutical

gory 2 OTC medicines Mytear® EYETECT® ALPITATTO Works on unpleasant eye itching due to pollens and other reasons CHARACTERISTICS Allergy symptoms to pollen, etc. can cause inflammation of the eyes. Th...

Mytear EYETECT ALPITATTO N | OTC Products, etc. | Products | SENJU Pharmaceutical

ory 2 OTC medicines Mytear® EYETECT® ALPITATTON Works on unpleasant eye itching due to pollens and other reasons CHARACTERISTICS Allergy symptoms to pollen, etc. can cause inflammation of the eyes. Th...

NewMytear CL-s | OTC Products, etc. | Products | SENJU Pharmaceutical

Category 3 OTC medicines New Mytear® CL-s Moisturizing the eye while wearing contact lenses CHARACTERISTICS This medicine can be used while wearing all types of contact lenses (hard, soft). Can be use...

adquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designation to the in-house developed compound having the development code SJP-0008 ...